The Global Impact of the Framingham Heart StudyWILSON, Peter W. F; GREENBERG, Henry.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, issn 0033-0620, 79 p.Serial Issue

From Framingham to the Framework Convention on Tobacco ControlYACH, Derek.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, pp 52-54, issn 0033-0620, 3 p.Article

From Framingham to North Karelia From Descriptive Epidemiology to Public Health ActionPUSKA, Pekka.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, pp 15-20, issn 0033-0620, 6 p.Article

The metabolic syndrome: A practical guide to origins and treatment: Part IIWILSON, Peter W. F; GRUNDY, Scott M.Circulation (New York, N.Y.). 2003, Vol 108, Num 13, pp 1537-1540, issn 0009-7322, 4 p.Article

Diabetes mellitus and coronary heart diseaseWILSON, Peter W. F.Endocrinology and metabolism clinics of North America. 2001, Vol 30, Num 4, issn 0889-8529, vi,857-881 [26 p.]Article

Evidence of Systemic Inflammation and Estimation of Coronary Artery Disease Risk : A Population PerspectiveWILSON, Peter W. F.The American journal of medicine. 2008, Vol 121, Num 10A, issn 0002-9343, S15-S20, SUPConference Paper

Assessing coronary heart disease risk with traditional and novel risk factorsWILSON, Peter W. F.Clinical cardiology. Supplement (Mahwah, NJ). 2004, Vol 27, Num 6, pp III.7-III.11Article

The metabolic syndrome: Practical guide to origins and treatment: Part IWILSON, Peter W. F; GRUNDY, Scott M.Circulation (New York, N.Y.). 2003, Vol 108, Num 12, pp 1422-1424, issn 0009-7322, 3 p.Article

Risk Scores for Prediction of Coronary Heart Disease : An UpdateWILSON, Peter W. F.Endocrinology and metabolism clinics of North America (Print). 2009, Vol 38, Num 1, issn 0889-8529, vii, 33-44 [13 p.]Article

The Contribution of the Framingham Heart Study to the Prevention of Cardiovascular Disease: A Global PerspectiveMENDIS, Shanthi.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, pp 10-14, issn 0033-0620, 5 p.Article

Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham viewWILSON, Peter W. F.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 3, issn 0889-8529, v, 467-481 [16 p.]Article

Lipids and Vascular Disease: A Framingham PerspectiveWILSON, Peter W. F.Global heart. 2013, Vol 8, Num 1, pp 25-33, 9 p.Article

A Message from the Laboratory Community to the National Cholesterol Education Program Adult Treatment Panel IVVESPER, Hubert W; WILSON, Peter W. F; RIFAI, Nader et al.Clinical chemistry (Baltimore, Md.). 2012, Vol 58, Num 3, pp 523-527, issn 0009-9147, 5 p.Article

Deciphering the Causes of Cardiovascular and Other Complex Diseases in Populations: Achievements, Challenges, Opportunities, and ApproachesYUSUF, Salim; ANAND, Sonia.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, pp 62-67, issn 0033-0620, 6 p.Article

Framingham Heart Study: The First 20 YearsOPPENHEIMER, Gerald M.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, pp 55-61, issn 0033-0620, 7 p.Article

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?RIDKER, Paul M; WILSON, Peter W. F; GRUNDY, Scott M et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 23, pp 2818-2825, issn 0009-7322, 8 p.Article

The Abu Dhabi Cardiovascular Program: The Continuation of FraminghamHAJAT, Cother; HARRISON, Oliver.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, pp 28-38, issn 0033-0620, 11 p.Article

The Framingham Heart Study's Impact on Global Risk AssessmentBITTON, Asaf; GAZIANO, Thomas.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, pp 68-78, issn 0033-0620, 11 p.Article

Parental transmission of type 2 diabetes: The Framingham offspring studyMEIGS, James B; CUPPLES, L. Adrienne; WILSON, Peter W. F et al.Diabetes (New York, NY). 2000, Vol 49, Num 12, pp 2201-2207, issn 0012-1797Article

The Framingham Study, Diabetes Mellitus and Cardiovascular Disease: Turning Back the ClockKENGNE, Andre Pascal; TURNBULL, Fiona; MACMAHON, Stephen et al.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, pp 45-51, issn 0033-0620, 7 p.Article

Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects : The bogalusa heart study. CommentaryWILSON, Peter W. F; SRINIVASAN, Sathanur R; MYERS, Leann et al.Hypertension (Dallas, Tex. 1979). 2006, Vol 48, Num 1, issn 0194-911X, 21-22,33-39 [9 p.]Article

Heritability of age at natural menopause in the framingham heart studyMURABITO, Joanne M; QIONG YANG; FOX, Caroline et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 6, pp 3427-3430, issn 0021-972X, 4 p.Article

Thiazolidinedione use is not associated with worse cardiovascular outcomes: A study in 28,332 high risk patients with diabetes in routine clinical practice Brief title: Thiazolidinedione use and mortalityROUSSEL, Ronan; HADJADJ, Samy; BHATT, Deepak L et al.International journal of cardiology. 2013, Vol 167, Num 4, pp 1380-1384, issn 0167-5273, 5 p.Article

Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With AtherothrombosisBHATT, Deepak L; EAGLE, Kim A; MAS, Jean-Louis et al.JAMA, the journal of the American Medical Association. 2010, Vol 304, Num 12, pp 1350-1357, issn 0098-7484, 8 p.Article

The Framingham Heart Study: Impact on the Prevention and Control of Cardiovascular Diseases in IndiaSRINATH REDDY, Kolli; SATIJA, Ambika.Progress in cardiovascular diseases. 2010, Vol 53, Num 1, pp 21-27, issn 0033-0620, 7 p.Article